Cart
0
Get 20% Free Customization In This Report
Buy this report from - $4176

Metabolomics Market by Product & Service (Metabolomics Instruments and Metabolomics Bioinformatics Tools and Services), Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Others), Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_17525
Pages: 165
Sep 2017 | 2852 Views
face gplus_n
Author's : Onkar Sumant and Gaurav Phalke
Tables: 48
Charts: 40
twit_n pr_n

Metabolomics Market Overview:

Global Metabolomics Market was valued at $1,379 million in 2016, and is estimated to reach $3,301 million by 2023, registering a CAGR of 13.2% from 2017 to 2023. Metabolomics is the study and analysis of the biochemical processes involving intermediates and byproducts of metabolic activities. These products are known as metabolomes, which reflect the cluster of all metabolites involved in various reactions in an organism, which include metabolic intermediates, signaling molecules, secondary metabolites, and hormones.

Metabolomics includes the utilization of various analytical techniques for the determination of metabolites such as, spectroscopy, chromatography, and multivariate analysis. Metabolites are closely related to the phenotype of an organism, and can be used for a wide range of applications such as, substantial equivalence testing, phenotyping of genetically modified plants, identification of gene function, and biotic-abiotic stress reaction analysis. Furthermore, it facilitates researchers and scientists to calculate physiological effects and observe adverse reaction of drugs on an organism.

The global metabolomics market is segmented based on product & service, application, indication, and geography. Based on product & service, it is divided into metabolomics instruments and metabolomics bioinformatics tools & services. The metabolomics instruments segment is further divided into separation techniques and detection techniques. The separation techniques segment is further classified into high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and capillary electrophoresis. The detection techniques segment is further categorized into mass spectrometry, nuclear magnetic resonance spectroscopy, and surface-based mass analysis. The metabolomics bioinformatics tools & services segment is further bifurcated into bioinformatics tools & databases and bioinformatics services. Based on application, the market is categorized into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and others. Based on indication, it is divided into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The global metabolomics market is driven by increase in adoption of metabolomics in precision medicine and advent of diagnostics tests for diagnosis of chronic diseases. Moreover, technological advancements in analytical techniques and upsurge in R&D expenditure are expected to boost the market growth.

The report provides extensive competitive analysis and profiles of key market players operating in metabolomics market, such as Agilent Technologies, Inc., Danaher Corporation, Biocrates Life Sciences AG, Bruker Corporation, LECO Corporation, Metabolon, Inc., Human Metabolome Technologies, Inc., Bio-Rad Laboratories, Inc., Shimadzu Corporation, Waters Corporation, and Thermo Fisher Scientific Inc.
The other players in the market include Kore Technologies, Ltd., Dani Instruments S.P.A., Perkinelmer, Inc., and Evans Analytical Group LLC.

Key Benefits:

  • The report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
  • Market estimations of the industry are provided based on the comprehensive analysis of the key developments in the industry.
  • In-depth analysis based on geography assists to understand the regional market and the strategic business planning.
  • The developmental strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the global market.

Metabolomics Market Key Segments:

By Product & Service

  • Metabolomics Instruments
    • Separation Techniques
      • High-performance Liquid Chromatography
      • Gas Chromatography
      • Ultra-performance Liquid Chromatography
      • Capillary Electrophoresis.
    • Detection Techniques
      • Mass Spectrometry
      • Nuclear Magnetic Resonance Spectroscopy
      • Surface-based Mass Analysis
  • Metabolomics Bioinformatics Tools & Services
    • Bioinformatics Tools and Database
    • Bioinformatics Services

By Application

  • Biomarker Discovery
  • Drug Discovery
  • Toxicology Testing
  • Nutrigenomics
  • Functional Genomics
  • Personalized Medicine
  • Others

By Indication

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • The Netherlands
    • Norway
    • Russia
    • Sweden
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • New Zealand
    • Taiwan
    • Thailand
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Chile
    • Columbia
    • Egypt
    • Iran
    • Israel
    • Turkey
    • Venezuela
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. TOP PLAYER POSITIONING
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Growth in demand for personalized medicines
3.5.1.2. Upsurge in R&D investment for development of metabolomics
3.5.1.3. Rise in global incidences of chronic diseases

3.5.2. Restraints

3.5.2.1. High cost of metabolic instruments
3.5.2.2. Scarcity of skilled professionals

3.5.3. Opportunities

3.5.3.1. Immense potential in disease diagnostics
3.5.3.2. Emerging prospect in human nutrition

Chapter: 4 METABOLOMICS MARKET, BY PRODUCT & SERVICES

4.1. OVERVIEW

4.1.1. Market size & forecast

4.2. METABOLOMICS INSTRUMENTS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.2.4. Separation technique

4.2.4.1. Market size & forecast
4.2.4.2. High-Performance Liquid Chromatography

4.2.4.2.1. Market size & forecast

4.2.4.3. Gas Chromatography

4.2.4.3.1. Market size & forecast

4.2.4.4. Ultra-Performance Liquid Chromatography

4.2.4.4.1. Market size & forecast

4.2.4.5. Capillary Electrophoresis

4.2.4.5.1. Market size & forecast

4.2.5. Detection technique

4.2.5.1. Market size & forecast
4.2.5.2. Mass Spectrometry

4.2.5.2.1. Market size & forecast

4.2.5.3. Nuclear Magnetic Resonance Spectroscopy

4.2.5.3.1. Market size & forecast

4.2.5.4. Surface-Based Mass Analysis

4.2.5.4.1. Market size & forecast

4.3. METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast
4.3.4. Bioinformatics Tools

4.3.4.1. Market size & forecast

4.3.5. Databases and Bioinformatics Services

4.3.5.1. Market size & forecast

Chapter: 5 METABOLOMICS MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size & forecast

5.2. BIOMARKER DISCOVERY

5.2.1. Market size & forecast

5.3. DRUG DISCOVERY

5.3.1. Market size & forecast

5.4. TOXICOLOGY TESTING

5.4.1. Market size & forecast

5.5. NUTRIGENOMICS

5.5.1. Market size & forecast

5.6. FUNCTIONAL GENOMICS

5.6.1. Market size & forecast

5.7. PERSONALIZED MEDICINE

5.7.1. Market size & forecast

5.8. OTHER APPLICATION

5.8.1. Market size & forecast

Chapter: 6 METABOLOMICS MARKET, BY INDICATION

6.1. OVERVIEW

6.1.1. Market size & forecast

6.2. CANCER

6.2.1. Market size & forecast

6.3. CARDIOVASCULAR DISORDERS

6.3.1. Market size & forecast

6.4. NEUROLOGICAL DISORDERS

6.4.1. Market size & forecast

6.5. INBORN ERRORS OF METABOLISM

6.5.1. Market size & forecast

6.6. OTHER INDICATIONS

6.6.1. Market size & forecast

Chapter: 7 METABOLOMICS MARKET, BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size & forecast
7.2.4. Market size & forecast

7.2.4.1. U.S. market size and forecast by product & services
7.2.4.2. U.S. market size and forecast by application
7.2.4.3. U.S. market size and forecast by indication
7.2.4.4. Canada market size and forecast by product & services
7.2.4.5. Canada market size and forecast by application
7.2.4.6. Canada market size and forecast by indication
7.2.4.7. Mexico market size and forecast by product & services
7.2.4.8. Mexico market size and forecast by application
7.2.4.9. Mexico market size and forecast by indication

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size & forecast
7.3.4. Market size & forecast

7.3.4.1. Germany market size and forecast by product & services
7.3.4.2. Germany market size and forecast by application
7.3.4.3. Germany market size and forecast by indication
7.3.4.4. France market size and forecast by product & services
7.3.4.5. France market size and forecast by application
7.3.4.6. France market size and forecast by indication
7.3.4.7. UK market size and forecast by product & services
7.3.4.8. UK market size and forecast by application
7.3.4.9. UK market size and forecast by indication
7.3.4.10. Italy market size and forecast by product & services
7.3.4.11. Italy market size and forecast by application
7.3.4.12. Italy market size and forecast by indication
7.3.4.13. Spain market size and forecast by product & services
7.3.4.14. Spain market size and forecast by application
7.3.4.15. Spain market size and forecast by indication
7.3.4.16. Netherlands market size and forecast by product & services
7.3.4.17. Netherlands market size and forecast by application
7.3.4.18. Netherlands market size and forecast by indication
7.3.4.19. Norway market size and forecast by product & services
7.3.4.20. Norway market size and forecast by application
7.3.4.21. Norway market size and forecast by indication
7.3.4.22. Russia market size and forecast by product & services
7.3.4.23. Russia market size and forecast by application
7.3.4.24. Russia market size and forecast by indication
7.3.4.25. Sweden market size and forecast by product & services
7.3.4.26. Sweden market size and forecast by application
7.3.4.27. Sweden market size and forecast by indication
7.3.4.28. Switzerland market size and forecast by product & services
7.3.4.29. Switzerland market size and forecast by application
7.3.4.30. Switzerland market size and forecast by indication
7.3.4.31. Rest of Europe market size and forecast by product & services
7.3.4.32. Rest of Europe market size and forecast by application
7.3.4.33. Rest of Europe market size and forecast by indication

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size & forecast

7.4.3.1. Japan market size and forecast by product & services
7.4.3.2. Japan market size and forecast by application
7.4.3.3. Japan market size and forecast by indication
7.4.3.4. China market size and forecast by product & services
7.4.3.5. China market size and forecast by application
7.4.3.6. China market size and forecast by indication
7.4.3.7. Australia market size and forecast by product & services
7.4.3.8. Australia market size and forecast by application
7.4.3.9. Australia market size and forecast by indication
7.4.3.10. India market size and forecast by product & services
7.4.3.11. India market size and forecast by application
7.4.3.12. India market size and forecast by indication
7.4.3.13. South Korea market size and forecast by product & services
7.4.3.14. South Korea market size and forecast by application
7.4.3.15. South Korea market size and forecast by indication
7.4.3.16. Taiwan market size and forecast by product & services
7.4.3.17. Taiwan market size and forecast by application
7.4.3.18. Taiwan market size and forecast by indication
7.4.3.19. Thailand market size and forecast by product & services
7.4.3.20. Thailand market size and forecast by application
7.4.3.21. Thailand market size and forecast by indication
7.4.3.22. New Zealand market size and forecast by product & services
7.4.3.23. New Zealand market size and forecast by application
7.4.3.24. New Zealand market size and forecast by indication
7.4.3.25. Rest of Asia-pacific market size and forecast by product & services
7.4.3.26. Rest of Asia-pacific market size and forecast by application
7.4.3.27. Rest of Asia-pacific market size and forecast by indication

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size & forecast

7.5.3.1. Brazil market size and forecast by product & services
7.5.3.2. Brazil market size and forecast by application
7.5.3.3. Brazil market size and forecast by indication
7.5.3.4. Saudi Arabia market size and forecast by product & services
7.5.3.5. Saudi Arabia market size and forecast by application
7.5.3.6. Saudi Arabia market size and forecast by indication
7.5.3.7. South Africa market size and forecast by product & services
7.5.3.8. South Africa market size and forecast by application
7.5.3.9. South Africa market size and forecast by indication
7.5.3.10. Chile market size and forecast by product & services
7.5.3.11. Chile market size and forecast by application
7.5.3.12. Chile market size and forecast by indication
7.5.3.13. Columbia market size and forecast by product & services
7.5.3.14. Columbia market size and forecast by application
7.5.3.15. Columbia market size and forecast by indication
7.5.3.16. Egypt market size and forecast by product & services
7.5.3.17. Egypt market size and forecast by application
7.5.3.18. Egypt market size and forecast by indication
7.5.3.19. Iran market size and forecast by product & services
7.5.3.20. Iran market size and forecast by application
7.5.3.21. Iran market size and forecast by indication
7.5.3.22. Israel market size and forecast by product & services
7.5.3.23. Israel market size and forecast by application
7.5.3.24. Israel market size and forecast by indication
7.5.3.25. Turkey market size and forecast by product & services
7.5.3.26. Turkey market size and forecast by application
7.5.3.27. Turkey market size and forecast by indication
7.5.3.28. Venezuela market size and forecast by product & services
7.5.3.29. Venezuela market size and forecast by application
7.5.3.30. Venezuela market size and forecast by indication
7.5.3.31. Rest of LAMEA market size and forecast by product & services
7.5.3.32. Rest of LAMEA market size and forecast by application
7.5.3.33. Rest of LAMEA market size and forecast by indication

Chapter: 8 COMPANY PROFILES

8.1. AGILENT TECHNOLOGIES INC.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments

8.2. BIOCRATES LIFE SCIENCES AG

8.2.1. Company overview
8.2.2. Operating business segments
8.2.3. Business performance
8.2.4. Key strategic moves and developments

8.3. BIO-RAD LABORATORIES, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance

8.4. BRUKER CORPORATION

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments

8.5. DANAHER CORPORATION

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance

8.6. HUMAN METABOLOME TECHNOLOGIES, INC.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments

8.7. LECO CORPORATION

8.7.1. Company overview
8.7.2. Operating business segments
8.7.3. Business performance
8.7.4. Key strategic moves and developments

8.8. METABOLON, INC.

8.8.1. Company overview
8.8.2. Operating business segments
8.8.3. Business performance
8.8.4. Key strategic moves and developments

8.9. SHIMADZU CORPORATION

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments

8.10. WATERS CORPORATION

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

 LIST OF TABLES

TABLE 1. GLOBAL METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 2. METABOLOMICS INSTRUMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. SEPARATION TECHNIQUE METABOLOMICS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 4. SEPARATION TECHNIQUE METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. DETECTION TEHNIQUE METABOLOMICS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 6. DETECTION TEHNIQUE METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 8. METABOLOMICS BIOINFORMATICS TOOLS AND SERVICES METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 10. BIOMARKER DISCOVERY METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. DRUG DISCOVERY METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. TOXICOLOGY TESTING METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 13. NUTRIGENOMICS METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. FUNCTIONAL GENOMICS METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. PERSONALIZED MEDICINE METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 16. OTHER APPLICATION METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. GLOBAL METABOLOMICS MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 18. CANCER METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. CARDIOVASCULAR DISORDERS METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. NEUROLOGICAL DISORDERS METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 21. INBORN ERRORS OF METABOLISM METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. OTHER INDICATIONS METABOLOMICS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 24. NORTH AMERICA METABOLOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 25. NORTH AMERIC METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 26. NORTH AMERICA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 27. NORTH AMERICA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 28. NORTH AMERIC METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 30. U.S. METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 31. CANADA METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 32. CANADA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 33. CANADA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 34. MEXICO METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 35. MEXICO METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 36. MEXICO METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 37. EUROPE METABOLOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 38. EUROPE METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 39. EUROPE METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 40. EUROPE METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 41. GERMANY METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 42. GERMANY METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 43. GERMANY METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 44. FRANCE METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 45. FRANCE METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 46. FRANCE METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 47. UK METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 48. UK METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 49. UK METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 50. ITALY METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 51. ITALY METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 52. ITALY METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 53. SPAIN METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 54. SPAIN METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 55. SPAIN METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 56. NETHERLANDS METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 57. NETHERLANDS METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 58. NETHERLANDS METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 59. NORWAY METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 60. NORWAY METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 61. NORWAY METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 62. RUSSIA METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 63. RUSSIA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 64. RUSSIA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 65. SWEDEN METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 66. SWEDEN METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 67. SWEDEN METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 68. SWITZERLAND METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 69. SWITZERLAND METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 70. SWITZERLAND METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 71. REST OF EUROPE METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 72. REST OF EUROPE METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 73. REST OF EUROPE METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 74. ASIA-PACIFIC METABOLOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 75. ASIA-PACIFIC METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 76. ASIA-PACIFIC METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 77. ASIA-PACIFIC METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 78. JAPAN METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 79. JAPAN METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 80. JAPAN METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 81. CHINA METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 82. CHINA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 83. CHINA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 84. AUSTRALIA METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 85. AUSTRALIA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 86. AUSTRALIA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 87. INDIA METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 88. INDIA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 89. INDIA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 90. SOUTH KOREA METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 91. SOUTH KOREA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 92. SOUTH KOREA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 93. TAIWAN METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 94. TAIWAN METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 95. TAIWAN METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 96. THAILAND METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 97. THAILAND METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 98. THAILAND METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 99. NEW ZEALAND METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 100. NEW ZEALAND METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 101. NEW ZEALAND METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 102. REST OF ASIA-PACIFIC METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 103. REST OF ASIA-PACIFIC METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 104. REST OF ASIA-PACIFIC METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 105. LAMEA METABOLOMICS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 106. LAMEA METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 107. LAMEA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 108. LAMEA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 109. BRAZIL METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 110. BRAZIL METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 111. BRAZIL METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 112. SAUDI ARABIA METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 113. SAUDI ARABIA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 114. SAUDI ARABIA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 115. SOUTH AFRICA METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 116. SOUTH AFRICA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 117. SOUTH AFRICA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 118. CHILE METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 119. CHILE METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 120. CHILE METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 121. COLUMBIA METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 122. COLUMBIA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 123. COLUMBIA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 124. EGYPT METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 125. EGYPT METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 126. EGYPT METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 127. IRAN METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 128. IRAN METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 129. IRAN METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 130. ISRAEL METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 131. ISRAEL METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 132. ISRAEL METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 133. TURKEY METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 134. TURKEY METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 135. TURKEY METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 136. VENEZUELA METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 137. VENEZUELA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 138. VENEZUELA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 139. REST OF LAMEA METABOLOMICS MARKET, BY PRODUCT & SERVICES, 2016-2023 ($MILLION)
TABLE 140. REST OF LAMEA METABOLOMICS MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 141. REST OF LAMEA METABOLOMICS MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 142. AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
TABLE 143. AGILENT TECHNOLOGIES INC.: OPERATING SEGMENTS
TABLE 144. BIOCRATES: COMPANY SNAPSHOT
TABLE 145. BIOCRATES: OPERATING SEGMENTS
TABLE 146. BIO-RAD: COMPANY SNAPSHOT
TABLE 147. BIO-RAD: OPERATING SEGMENTS
TABLE 148. BIO-RAD: PRODUCT PORTFOLIO
TABLE 149. BRUKER: COMPANY SNAPSHOT
TABLE 150. BRUKER: OPERATING SEGMENTS
TABLE 151. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 152. DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 153. HMT: COMPANY SNAPSHOT
TABLE 154. HMT CORPORATION: OPERATING SEGMENTS
TABLE 155. LECO: COMPANY SNAPSHOT
TABLE 156. LECO: OPERATING SEGMENTS
TABLE 157. METABOLON: COMPANY SNAPSHOT
TABLE 158. METABOLON: OPERATING SEGMENTS
TABLE 159. SHIMADZU: COMPANY SNAPSHOT
TABLE 160. SHIMADZU: OPERATING SEGMENTS
TABLE 161. WATERS: COMPANY SNAPSHOT
TABLE 162. WATERS: OPERATING SEGMENTS
TABLE 163. WATERS: PRODUCT PORTFOLIO

 LIST OF FIGURES

FIGURE 1. METABOLOMICS MARKET: MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL DNA SEQUENCING MARKET, BY APPLICATION
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE AND DISTRIBUTION
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 6. TOP PLAYER POSITIONING: GLOBAL METABOLOMICS MARKET, 2016
FIGURE 7. BARGAINING POWER OF BUYERS
FIGURE 8. BARGAINING POWER OF SUPPLIERS
FIGURE 9. THREAT OF NEW ENTRANTS
FIGURE 10. THREAT OF SUBSTITUTION
FIGURE 11. COMPETITIVE RIVALRY
FIGURE 12. METABOLOMICS MARKET: PRODUCT & SERVICES SEGMENATION
FIGURE 13. GLOBAL METABOLOMICS MARKET FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY, 2016-2023 ($MILLION)
FIGURE 14. GLOBAL METABOLOMICS MARKET FOR GAS CHROMATOGRAPHY, 2016-2023 ($MILLION)
FIGURE 15. GLOBAL METABOLOMICS MARKET FOR ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY, 2016-2023 ($MILLION)
FIGURE 16. GLOBAL METABOLOMICS MARKET FOR CAPILARY ELECTROPHORESIS, 2016-2023 ($MILLION)
FIGURE 17. GLOBAL METABOLOMICS MARKET FOR MASS SPECTROMETRY, 2016-2023 ($MILLION)
FIGURE 18. GLOBAL METABOLOMICS MARKET FOR NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 2016-2023 ($MILLION)
FIGURE 19. GLOBAL METABOLOMICS MARKET FOR SURFACE-BASED MASS ANALYSIS, 2016-2023 ($MILLION)
FIGURE 20. GLOBAL METABOLOMICS MARKET FOR BIOINFORMATICS TOOLS, 2016-2023 ($MILLION)
FIGURE 21. GLOBAL METABOLOMICS MARKET FOR DATABASES AND BIOINFORMATICS SERVICES, 2016-2023 ($MILLION)
FIGURE 22. METABOLOMICS MARKET: BY APPLICATION SEGMENTATION
FIGURE 23. METABOLOMICS MARKET: BY INDICATION
FIGURE 24. AGILENT TECHNOLOGIES INC.: NET SALES, 2014-2016 ($MILLION)
FIGURE 25. AGILENT TECHNOLOGIES INC.: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 26. AGILENT TECHNOLOGIES INC.: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 27. BIO-RAD: NET SALES, 2014-2016 ($MILLION)
FIGURE 28. BIO-RAD: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 29. BIO-RAD: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 30. BRUKER: NET SALES, 2014-2016 ($MILLION)
FIGURE 31. BRUKER: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 32. BRUKER: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 33. DANAHER CORPORATION: NET SALES, 2014-2016 ($MILLION)
FIGURE 34. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 35. DANAHER CORPORATION: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 36. SHIMADZU: NET SALES, 2014-2016 ($MILLION)
FIGURE 37. SHIMADZU CORPORATION: REVENUE BY SEGMENT, 2016 (%)
FIGURE 38. SHIMADZU CORPORATION: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 39. WATERS: NET SALES, 2014-2016 ($MILLION)
FIGURE 40. WATERS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)

 

Metabolomics is a rapidly growing branch of medical science that manipulates sophisticated analytical technologies using multivariant, statistical methods for data collection & interpretation to classify & quantify cellular metabolites. In the recent years, huge investment was made by private & government entities to develop analytical approaches to examine various cell products such as, varieties of proteins, metabolites, and gene expressions. These approaches are generally known as “omics,” and they are crucial to understand an organism’s biological structure and metabolic activities.

Increase in prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases has led to growing adoption of advanced diagnostics tests, development of novel biomarker detection, and drug discovery technologies that use metabolomics. In addition, rise in demand for personalized medicine and increase in investment for R&D activities by government & private organizations are expected to fuel the demand for metabolomics product & service. Constant development in metabolomics platforms is expected to find applications in numerous cell culture applications, thereby increasing scope of metabolomics technology across diverse medical application areas.

North America is a global leader in the market, and accounted for the highest market share in 2016, owing to high adoption rate of metabolomics technology in the region. Moreover, established biotechnological and pharmaceutical companies in the region augment the development of metabolomics and auxiliary tools. The European region possesses lucrative potential for market players due to increased funding for metabolomics R&D in the region. The adoption of metabolomics is relatively lower in the Asia-Pacific and LAMEA regions. However, increase in burden of chronic diseases in the developing countries, such as China and India due to the large population base is expected to boost the growth of the industry.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Request sample

OR

Purchase Full Report of
Metabolomics Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $4176
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo